Dendritic cell therapy in composite tissue allotransplantation

Transplant Proc. 2009 Mar;41(2):537-8. doi: 10.1016/j.transproceed.2009.01.011.

Abstract

Dendritic cells (DCs) are bone marrow-derived, professional antigen-presenting cells, with inherent tolerogenic function. The ability of immature or maturation-resistant DCs to regulate alloantigen-specific T-cell responses and to promote tolerance induction has been well demonstrated in organ and bone marrow transplantation. Recent data suggest that DCs can also promote long-term survival of composite tissue allografts in the absence of continued immunosuppressive drug therapy.

MeSH terms

  • Bone Marrow Cells / immunology
  • Dendritic Cells / immunology*
  • Dendritic Cells / transplantation
  • Graft Survival / physiology*
  • Humans
  • Immune Tolerance
  • Immunosuppression Therapy / methods
  • Immunosuppressive Agents / therapeutic use
  • Spleen / immunology
  • T-Lymphocytes / immunology
  • Tissue Transplantation / pathology*
  • Transplantation, Homologous / immunology*
  • Transplantation, Homologous / pathology

Substances

  • Immunosuppressive Agents